Benjamin Moritz

Benjamin Moritz is a Business Development Manager at ExcellGene SA since January 2022, focusing on identifying opportunities to advance client projects in clinical trials. Previous experience includes serving as Head of Cell Line Development at Ichnos Sciences, leading an international team and managing research activities, and as Principal Scientist at Glenmark Pharmaceuticals, where oversight of the Cell Line Development team was emphasized. Benjamin's career began with roles at Roche, where work as a Research Scientist and a Ph.D. student advanced proficiency in cell line development and optimization. Educational credentials include an Executive MBA from Quantic School of Business and Technology, a Ph.D. in Epigenetics from Ludwig-Maximilians-Universität München, and advanced degrees in Molecular Biology and Biology from Technical University of Munich and University of Konstanz, respectively.